Table 5 Input parameters for base analysis

From: Cost burden and net monetary benefit loss of neonatal hypoglycaemia

Cerebral palsy Epilepsy Visual disorders Learning disability Probability Utility [46] Post-discharge costa
Severe Mild-moderate Hypoglycaemia No hypoglycaemia
75.9656% 96.4347% 0.876 $ 0.00
Yes 14.6016% 0.9601% 0.476 $31,784.45
Yes 3.0326% 0.0606% 0.276 $31,784.45
Yes 0.5663% 1.6802% 0.547 $4250.65
Yes Yes 0.1089% 0.0167% 0.476 $31,784.45
Yes Yes 0.0226% 0.0011% 0.276 $31,784.45
Yes 0.4048% 0.6192% 0.552 $5196.11
Yes Yes 0.0778% 0.0062% 0.476 $31,784.45
Yes Yes 0.0162% 0.0004% 0.276 $31,784.45
Yes Yes 0.0030% 0.0108% 0.547 $5196.11
Yes Yes Yes 0.0006% 0.0001% 0.476 $31,784.45
Yes Yes Yes 0.0001% 0.0000% 0.276 $24,748.93
Yes 4.1669% 0.2029% 0.348 $31,211.41
Yes Yes 0.8009% 0.0020% 0.348 $80,894.69
Yes Yes 0.1663% 0.0001% 0.276 $80,894.69
Yes Yes 0.0311% 0.0035% 0.348 $31,211.41
Yes Yes Yes 0.0060% 0.0000% 0.348 $80,894.69
Yes Yes Yes 0.0012% 0.0000% 0.276 $31,211.41
Yes Yes 0.0222% 0.0013% 0.348 $80,894.69
Yes Yes Yes 0.0043% 0.0000% 0.348 $80,894.69
Yes Yes Yes 0.0009% 0.0000% 0.276 $80,894.69
Yes Yes Yes 0.0002% 0.0000% 0.348 $31,211.41
Yes Yes Yes Yes 0.0000% 0.0000% 0.348 $80,894.69
Yes Yes Yes Yes 0.0000% 0.0000% 0.276 $80,894.69
  1. aPer patient, mean annual, 2018 NZ dollars (to convert NZ$ to US$ multiply by 0.6938)